Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mereo Biopharma Group Plc ADR
(NQ:
MREO
)
4.830
+0.320 (+7.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mereo Biopharma Group Plc ADR
< Previous
1
2
3
4
Next >
Ultragenyx Announces First Patients Dosed in Phase 3 Program Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
July 06, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 07, 2023
Via
Benzinga
Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
June 06, 2023
Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading.
Via
Benzinga
Why Ultragenyx Pharma Stock Is Trading Higher Premarket Today
June 06, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 06, 2023
It's time for another dive into the latest pre-market stock movers as we check out all of the news moving shares on Tuesday morning!
Via
InvestorPlace
Mereo BioPharma to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference
May 23, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 08, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
May 05, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the 22nd Annual Needham Healthcare Conference
April 13, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights
March 28, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Provides Regulatory Updates on Alvelestat for the Treatment of Alpha-1-Antitrypsin Deficiency-Associated Lung Disease
March 21, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
February 13, 2023
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 52.5% to $0.7050 in pre-market trading after jumping over 72% on Friday.
Via
Benzinga
Mereo BioPharma to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference
February 08, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
Via
Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
November 08, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
December 21, 2022
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...
Via
Benzinga
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
November 02, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
October 28, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma to Host Alvelestat R&D Update Call on October 31, 2022
October 24, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
October 21, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Rubric Capital Management Comments on Mereo BioPharma Updated Operating Plan
October 18, 2022
From
Rubric Capital Management LP
Via
Business Wire
Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value
October 18, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of Alpha-1 Antitrypsin Deficiency (AATD)-associated Lung Disease
October 17, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Confirms Receipt of a Valid Notice Requiring it to Convene a General Meeting of Shareholders
October 03, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Rubric Capital Management Increases Slate of Proposed Mereo BioPharma Director Nominees to Five
October 03, 2022
From
Rubric Capital Management LP
Via
Business Wire
Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
September 14, 2022
From
Rubric Capital Management LP
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.